Description

5-(3-Hydroxymethyl-3-Methyl-1-Triazeno)Imidazole-4-Carboxamide is a specialized heterocyclic organic compound featuring a unique triazeno-imidazole carboxamide structure. This compound is of significant interest in advanced pharmaceutical research and development, particularly as a key synthetic intermediate or a potential pharmacophore. It is primarily utilized by research institutions and pharmaceutical companies engaged in the discovery and synthesis of novel therapeutic agents, including anticancer and antiviral candidates.

Application

• Pharmaceutical Intermediate: Serves as a critical building block in the synthesis of novel drug candidates, particularly in oncology research.
• Biochemical Research: Used as a reference standard or reagent in studies investigating enzyme inhibition and cellular signaling pathways.
• Anticancer Agent Development: Explored for its potential as a prodrug or active moiety in chemotherapeutic compounds due to its triazeno functional group.
• Academic Research: Employed in universities and R&D labs for methodological studies in organic synthesis and heterocyclic chemistry.
• Preclinical Studies: Utilized in the early-stage development and screening of new molecular entities for various therapeutic areas.

Basic Information

Product Name	5-(3-Hydroxymethyl-3-Methyl-1-Triazeno)Imidazole-4-Carboxamide
CAS No.	75513-70-1
Molecular Formula	C8H12N6O2
Molecular Weight	224.22 g/mol
Synonyms	5-(3-Hydroxymethyl-3-methyl-1-triazeno)imidazole-4-carboxamide; 5-[(3-Hydroxy-3-methyl-1-triazen-1-yl)methyl]-1H-imidazole-4-carboxamide; 5-(3-Hydroxy-3-methyltriaz-1-en-1-yl)methyl-1H-imidazole-4-carboxamide; Triazenoimidazolecarboxamide; NSC 363812; Lometrexol intermediate analog; Triazene derivative of imidazole carboxamide.
EINECS	Contact for details

Quality Control

Our 5-(3-Hydroxymethyl-3-Methyl-1-Triazeno)Imidazole-4-Carboxamide is produced under strict quality management protocols to ensure batch-to-batch consistency and high purity suitable for research applications. Each lot is accompanied by a comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles. We adhere to cGMP guidelines where applicable to support our clients' regulatory and compliance needs in pharmaceutical development.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials. Due to its light-sensitive nature, handling and storage should minimize exposure to direct light.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 95.0%
Related Substances (HPLC)	Total impurities ≤ 5.0%
Water Content (KF)	≤ 2.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.